Letter Regarding “Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation”

IF 2.4 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Ahmed M. Gazer, Elsayed Hammad
{"title":"Letter Regarding “Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation”","authors":"Ahmed M. Gazer,&nbsp;Elsayed Hammad","doi":"10.1002/clc.70072","DOIUrl":null,"url":null,"abstract":"<p>We read with interest the recent publication by Khan et al. [<span>1</span>] in <i>Clinical Cardiology</i> titled “<i>Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation</i>”. While the article provides valuable insights into different furosemide strategies in managing patients with acute decompensated heart failure, we noticed an error in Table 1, which presents the baseline patient characteristics. Specifically, the reported patient population underwent a sudden and significant reduction in the arms of the study; for example, an initial cohort of 479 patients reduced or reported to only 14 patients in the T1 arm (intravenous bolus infusion in the table). This error has the potential to misinterpret the results and conclusions of the study.</p><p>We believe these clarifications are essential for readers to fully comprehend the validity and applicability of the study's findings.</p><p>We kindly request the authors and the journal to rectify this error promptly. A corrected version of Table 1 should be published to ensure accurate interpretation of the study findings.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":10201,"journal":{"name":"Clinical Cardiology","volume":"48 1","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669891/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Cardiology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/clc.70072","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

We read with interest the recent publication by Khan et al. [1] in Clinical Cardiology titled “Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation”. While the article provides valuable insights into different furosemide strategies in managing patients with acute decompensated heart failure, we noticed an error in Table 1, which presents the baseline patient characteristics. Specifically, the reported patient population underwent a sudden and significant reduction in the arms of the study; for example, an initial cohort of 479 patients reduced or reported to only 14 patients in the T1 arm (intravenous bolus infusion in the table). This error has the potential to misinterpret the results and conclusions of the study.

We believe these clarifications are essential for readers to fully comprehend the validity and applicability of the study's findings.

We kindly request the authors and the journal to rectify this error promptly. A corrected version of Table 1 should be published to ensure accurate interpretation of the study findings.

The authors declare no conflicts of interest.

致编辑的信:对[急性失代偿性左心室衰竭和心房颤动患者的快速剂量与持续输注呋塞米的结果]的更正。
我们最近非常感兴趣地回顾了[khan等人]在《临床心脏病学》上发表的题为“急性失代偿性左心衰和房颤患者的快速注射剂量与持续输注速尿的结果”的文章(1)。这项研究涉及临床实践的一个关键领域,我们感谢作者在探索这一主题方面所做的努力。然而,在我们的回顾中,我们观察到一些需要澄清的地方,以便更好地理解所提出的发现:表1中的患者人数在研究论文中:报告的患者人数突然显著减少。这一差异在研究中没有得到充分解释。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Cardiology
Clinical Cardiology 医学-心血管系统
CiteScore
5.10
自引率
3.70%
发文量
189
审稿时长
4-8 weeks
期刊介绍: Clinical Cardiology provides a fully Gold Open Access forum for the publication of original clinical research, as well as brief reviews of diagnostic and therapeutic issues in cardiovascular medicine and cardiovascular surgery. The journal includes Clinical Investigations, Reviews, free standing editorials and commentaries, and bonus online-only content. The journal also publishes supplements, Expert Panel Discussions, sponsored clinical Reviews, Trial Designs, and Quality and Outcomes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信